Community Practice Connections: 4th Annual Miami Lung Cancer Conference
Webcast
OVERVIEW
Community Practice Connections: 4th Annual Miami Lung Cancer Conference is organized by Physicians Education Resource, LLC (PER) and will be held during Jun 30, 2017 - Jun 30, 2018.
The target audience for this medical event is directed toward oncologists involved in the treatment and management of patients with lung cancers. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of lung cancers may also participate. This CME Conference has been approved for a maximum of 7.00 AMA PRA Category 1 Credits.
Conference Overview :
This Conference is designed to provide a dynamic discussion of current and evolving paradigms in the treatment of lung cancer, including immunotherapies in development, molecular subsets and targeted agents, the emergence of liquid biopsies, and the management of patients without actionable mutations.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Discuss evidence-based recommendations regarding tumor tissue testing and its role in therapeutic selection for patients with non–small cell lung caner (NSCLC)
• Assess clinical decision making along multiple lines of care concerning the use of chemotherapeutic, targeted, and immuno-oncology strategies in the setting of NSCLC
• Discuss evolving data sets on immuno-oncology strategies and their use in lung cancers
• Describe the role of cytotoxic and antiangiogenic approaches in the management of advanced NSCLC
• Explain optimized strategies to target oncogenic drivers in frontline settings and beyond disease progression
• Describe advances and future directions for care in the management of squamous NSCLC, as well as treatment considerations for special populations of patients with lung cancer
• Integrate personalized approaches to manage challenging cases and real-world clinical scenarios in advanced lung cancer settings
Additional details will be posted as soon as they are available.
The target audience for this medical event is directed toward oncologists involved in the treatment and management of patients with lung cancers. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of lung cancers may also participate. This CME Conference has been approved for a maximum of 7.00 AMA PRA Category 1 Credits.
Conference Overview :
This Conference is designed to provide a dynamic discussion of current and evolving paradigms in the treatment of lung cancer, including immunotherapies in development, molecular subsets and targeted agents, the emergence of liquid biopsies, and the management of patients without actionable mutations.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Discuss evidence-based recommendations regarding tumor tissue testing and its role in therapeutic selection for patients with non–small cell lung caner (NSCLC)
• Assess clinical decision making along multiple lines of care concerning the use of chemotherapeutic, targeted, and immuno-oncology strategies in the setting of NSCLC
• Discuss evolving data sets on immuno-oncology strategies and their use in lung cancers
• Describe the role of cytotoxic and antiangiogenic approaches in the management of advanced NSCLC
• Explain optimized strategies to target oncogenic drivers in frontline settings and beyond disease progression
• Describe advances and future directions for care in the management of squamous NSCLC, as well as treatment considerations for special populations of patients with lung cancer
• Integrate personalized approaches to manage challenging cases and real-world clinical scenarios in advanced lung cancer settings
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links